Mutant DHFR Prevalence and Pyrimethamine Resistance among Asymptomatic Adolescents in Kwara State
https://dx.doi.org/10.4314/njpar.v44i1.19
Keywords:
mutant alleles, prevalence, drug resistance, Malaria parasiteAbstract
Plasmodium falciparum malaria remains a leading public health problem in sub-Saharan Africa and its control is seriously challenged by drug resistance. Resistance to sulfadoxine-pyrimethamine is mediated by point mutations in genes encoding the target enzymes dihydrofolate reductase (pfdhfr) and dihydropteroate synthase (pfdhps). Blood from a total of 176 subjects aged 11-19 years from Ilorin East and Irepodun Local Government areas (LGAs) was examined for mutant alleles of the Plasmodium falciparum dihydrofolate reductase gene by polymerase chain reaction (PCR) at codon 51 and 108 respectively. Rapid Diagnostic Test kits were used for the malaria test. Of the 176 participants, 73 (41.5%) subjects tested positive for malaria parasite while 95 (54.0%) tested negative. For both N51I and S108N SNPscreening, mutant alleles were dominant over the wild type. The Iponrin community (Ilorin East LGA) recorded the highest percentage of mutant alleles 14 (33.33%) of the N51I SNP, while the Igbonla community (Irepodun LGA) had the least number of mutant alleles 8 (19.04%). On the other hand, the Alakuko community recorded the highest number of alleles 14 (31.80%) for S108N mutant while the Igbonla community (Irepodun LGA) had the least number of mutant alleles 8 (18.18%). There was widespread pyrimethamine resistance among the studied population and the malaria parasite remains persistent among the studied population. Therefore, there is a need for monitoring antimalarial drug resistance in Nigeria for prompt management of the antimalarial drug resistance menace.
References
World Health Organization (2021). World Malaria Report 2021. Geneva: World Health Organization.https://www.who.int/teams/gl obal-malaria-programme/reports/worldmalaria-report-2021 (accessed 19 October 2022)
Kimbi, H., Keka, F., Nyabeyeu, H.,Ajeagah, H., and Tonga, C. (2012). An Update of Asymptomatic Falciparum Malaria in School Children in Muca, Southwest Cameroon. Journal of Bacteriology and Parasitology 3(154): 2.
Aguzie, I. O. N. (2018). Pregnancy- associated Malaria, Challenges and Prospects in Sub-Saharan Africa. Clinics in Mother and Child Health 15(1): 1-8. doi:10.4172/2090-7214.1000282
Jeff, D., and David, N. (2021). Ethical considerations for introducing RTS, S/AS01 in countries with moderate to high Plasmodium falciparum mala ri a transmission. The Lancet Global Health 9(12): e1642-e1643
Rudrapal, M., and Chetia, D. (2021). Malaria and Recent Developments in Antimalarial Drugs. In: Neglected Tropical Diseases and Phytochemicals in Drug Discovery pp. 499 – 542. doi:10.1002/9781119617143.ch21
Olasehinde, G. I., Ojurongbe, O. O., Fagade, E. O., Egwari, L. O., Ajayi, A. A., Adeyeba, O. A., Ruchi, S. (2014). Detection of Molecular Markers of Antima l a ri a l Drug Re sist anc e in Plasmodium falciparum from South- Western Nigeria. Covenant Journal of Physical and Life Sciences 1: 61–75.
Slater, L., Betson, M., Ashraf, S., Sargison, N., and Chaudhry, U. (2021). Current methods for the detection of antimalarial drug resistance in Plasmodium parasites infecting humans. Acta Tropica 216:105828.https://doi.10.1016/j.actatropica.2021.105828.
Ojurongbe, O., Nguetse, C. N., Fayemiwo, S. A., Falade, C. O., Ojurongbe, T. A., Thomas, B.N., Meyer, C. G., and Velavan, T. P. (2018). High prevalence of dihydrofolate reductase gene mutations in Plasmodium falciparum parasites among pregnant women in Nigeria after reported
use of sulfadoxine-pyrimethamine.Pathogens and Global Health 112(2): 86–92 doi:10.1080/20477724.2017.1422615
Dondorp, A. M., Nosten, F., Yi, P. (2009). Artemisinin resistance in Plasmodium falciparum malaria. The New England Journal of Medicine 361: 55–467.doi:doi.org/10.1056/NEJMoa0808859.
Bansal, D., Bharti, P. K., Acharya, A.(2019). Molecular surveillance of putative drug resistance markers of antifolate and artemisinin among imported Plasmodium falciparum in Qatar. Pathogens and Global Health 113: 158 – 166. doi:10.1080/20477724.2019.1639018
Quan, H., Igbasi, U., Oyibo, W., Omilabu, S., Chen, S. B., Shen, H. M., Okolie, C., Chen, J. H., and Zhou, X. N. (2020). High multiple mutations of Plasmodium falciparum-resistant genotypes to sulphadoxine-pyrimethamine in Lagos,Nigeria. Infectious Diseases of Poverty 9(1): 1-11 doi:10.1186/s40249-020-00712-4
Agomo, C. O., Oyibo, W. A., Sutherland, C., Hallet, R., and Oguike, M. (2016). Assessment of markers of antimalarial drug resistance in Plasmodium falciparumisolates from pregnant women in Lagos, Nigeria. PLoS One 11(1): e0146908.doi:10.1371/journal.pone.0146908
Boukoumba, F. M., Lekana-Douki, J. B., Matsiegui, P. B., Moukodoum, D. N., Adegnika, A. A., and Oyegue-Liabagui, S. L. (2021). High prevalence of genotypes associated with sulfadoxine/pyrimethamine resistance in the rural area of Fougamou, Gabon. Journal of Global Antimicrobial Resistance 25: 181 – 186. doi:10.1016/j.jgar.2021.03.003
Ogouyèmi-Hounto, A., Ndam, N.T., Kinde Gazard, D., D’Almeida, S., Koussihoude, L., Ollo, E., Azagnandji, C., Bello, M., Chippaux, J. P., and Massougbodji, A.(2013). Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy. Malaria Journal 12(1): 1-8. doi:10.1186/1475-2875-12-147
Oguike, M. C., Falade, C. O., Shu, E., Enato, I. G., Watila, I., Baba, E. S., Bruce, J., Webster, J., Hamade, P., Meek, S., and Chandramohan, D. (2016). Moleculardeterminants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps 431V. Int e rnational Journal forParasitology: Drugs Drug Resistance 6(3):220–229. doi:10.1016/j.ijpddr.2016.08.004
Falade, C. O., Yusuf, B. O., Fadero, F. F., Mokuolu, O. A., Hamer, D. H., and Salako, L. A. (2007). Intermittentpreventive treatment with sulphadoxinepyrimethamine is effective in preventing maternal and placental malaria in Ibadan, South-Western Nigeria. Malaria Journal
(1): 1-8 doi:doi.org/10.1186/1475-2875-6-88.
Happi, C. T., Gbotosho, G. O., Folarin, O. A., Akinboye, D. O., Yusuf, B. O., Ebong, O. O., Sowunmi, A., Kyle, D. E., Milhous, W., Wirth, D. F. and Oduola, A. M. (2005). Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance inmalaria-infected patients from Nigeria. Acta Tropica 95(3): 19aa83– 193.doi:10.1016/j.actatropica.2005.06.015
Orosun, M. M., Oyewumi, K. J., Usikalu, M. R., and Onumejor, C. A. (2020). “Dataset on radioactivity measurement of Beryllium mining field in Ifelodun and Gold mining field in Moro, Kwara State, Northcentral Nigeria.” Data in Brief 31: 105888
Shittu, O., Opeyemi, O. A., Ajibaye, O., Omotesho, B. O., and Fakayode, O.(2018). Evaluation of the clinical proficiency of RDTs, microscopy and nested PCR in the diagnosis of symptomatic malaria in Ilorin, north-central, Nigeria. Open Access Macedonian Journal of Medi cal Sc i enc e s 6: 1032–1040.doi:10.3889/oamjms.2018.218
Kitojo, C., Chacky, F., Kigadye, E. S., Mugasa, J. P., Lusasi, A., Mohamed, A., Walker, P., Reaves, E. J., Gutman, J. R., and Ishengoma, D. S. (2020). Evaluation of a single screen and treatment strategy to detect asymptomatic malaria among pregnant women from selected health
facilities in Lindi region, Tanzania. Malaria Journal 19(1): 1-8. doi:10.1186/s12936-020-03513-0
Oboh, M. A., Oriero, E. C., Ndiaye, T., Badiane, A. S., Ndiaye, D., andAmambua-Ngwa, A. (2021). Comparative analysis of four malaria diagnostic tools and implications for malaria treatment insouthwestern Nigeria. International Journal of Infectious Diseases 108: 377–381.
doi:10.1016/j.ijid.2021.05.049
Umunnakwe, F. A., Idowu, E. T., Ajibaye, O., Etoketim, B., Akindele, S., Shokunbi, A. O., Otubanjo, O. A., Awandare, G. A., Amambua-Ngwa, A., and Oyebola, K. M. (2019). High cases of submicroscopicPlasmodium falciparum infections in a suburban population of Lagos, Nigeria.
Malaria Journal 18(1): 1-8.doi:10.1186/s12936-019-3073-7
Adetunji, A. A., Ademuyiwa, A. J., Alo, G. N., and Adejumo, A. O. (2021). Geoadditive modelling of children under-five sleeping under Insecticide-treated nets in Nigeria. GeoJournal 87(4): 2479-2490.doi:10.1007/s10708-021-10385-7
Lema, S. Y., Abdullahi, K., Yahaya, M. A., Ibrahim, J., Suleiman, J., and Hashimu, M.(2021). Evaluation of malaria parasites in relation to Blood Groups among participants attending tertiary health facility, Sokoto State, Nigeria. Nigerian Journal of Parasitology 42(2): 251 – 257. doi:10.4314/njpar.v42i2.9
Sama, S. O., Chiamo, S. N., Taiwe, G. S., Njume, G. E., and Ngole Sumbele, I. U. (2021). Microcytic and Malarial Anaemia Prevalence in Urban Children ≤15 Years in the Mount Cameroon Area: A CrossSectional Study on Risk Factors. Anemia. doi:10.1155/2021/5712309
Edosomwan, E. U., Evbuomwan, I. O., Agbalalah, C., Dahunsi, S. O., and Abhulimhen-Iyoha, B. I. (2020). Malaria coinfection with Neglected Tropical Diseases (NTDs) in children at Internally Displaced Persons (IDP) camp in Benin City, Nigeria. Heliyon 6(8): e04604 doi:10.1016/j.heliyon.2020.e04604
Mawili-Mboumba, D. P., Akotet, M. K. B., Kendjo, E., Nzamba, J., Medang, M. O., Mbina, J. R. M., and Kombila, M. (2013). Increase in malaria prevalence and age of at risk population in different areas of Gabon. Malaria Journal 12(1): 1 - 7 doi:10.1186/1475-2875-12-3
Berzosa, P., De Lucio, A., Romay-Barja, M., Herrador, Z., González, V., García, L., Fernández-Martínez, A., SantanaMorales, M., Ncogo, P., Valladares, B., and Riloha, M.(2018). Comparison of three diagnostic methods (microscopy, RDT, and PCR) for the detection of malaria parasites in representative samples from EquatorialGuinea 11 Medical and Health Sciences 1108 Medical Microbiology. Malaria Journal 17(1): 1-2 doi:10.1186/s12936-018- 2481-4
Ruizendaal, E., Tahita, M.C., Geskus, R.B., Versteeg, I., Scott, S., d’Alessandro, U., Lompo, P., Derra, K., Traore- Coulibaly, M., de Jong, M.D., andSchallig, H.D. (2017). Increase in the prevalence of mutations associated with sulfadoxine-pyrimethamine resistance inPlasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso. Malaria Journal 16 (1): 1-15 doi:10.1186/s12936-017-1831-y
Iwalokun, B., Iwalokun, S., Adebodun, V., and Balogun, M. (2015). Carriage of mutant dihydrofolate reductase and dihydropteroate synthase genes among Plasmodium falciparum isolates recovered from pregnant women with asymptomatic infection in Lagos, Nigeria. Medical Principles and Practice 24: 436–443
Oguike, M., Falade, C., Shu, E., Enato, I., Watila, I., and Baba, E. (2016). Molecular determinants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum in Nigeria and the regional emergence of dhps431V. Int e rnational Journal forParasitology: Drugs Drug Resistance 6:
–229
Fagbemi, K., Adebusuyi, S., Nderu, D., Adedokun, S., Pallerla, S., Amoo, A., Thomas, B., Velavan, T., and Ojurongbe, O. (2020). Analysis of sulphadoxine–pyrimethamine resistance- associated mutations in Plasmodium falciparum isolates obtained from asymptomatic pregnant women in Ogun State, Southwest Nigeria. Infection Genetics and Evolution 85: 104503
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Nigerian Journal of Parasitology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
